325 related articles for article (PubMed ID: 15737190)
1. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Katz KA; Marcil I; Stern RS
J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
[TBL] [Abstract][Full Text] [Related]
3. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
5. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
7. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Stern RS; Bagheri S; Nichols K;
J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
[TBL] [Abstract][Full Text] [Related]
8. Non-melanoma skin cancer, sun exposure and sun protection.
Calzavara-Pinton P; Ortel B; Venturini M
G Ital Dermatol Venereol; 2015 Aug; 150(4):369-78. PubMed ID: 26186380
[TBL] [Abstract][Full Text] [Related]
9. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
10. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
11. Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort.
Bräuner EV; Loft S; Sørensen M; Jensen A; Andersen CE; Ulbak K; Hertel O; Pedersen C; Tjønneland A; Krüger Kjær S; Raaschou-Nielsen O
PLoS One; 2015; 10(8):e0135642. PubMed ID: 26274607
[TBL] [Abstract][Full Text] [Related]
12. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
14. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.
Robinson SN; Zens MS; Perry AE; Spencer SK; Duell EJ; Karagas MR
J Invest Dermatol; 2013 Aug; 133(8):1950-5. PubMed ID: 23344461
[TBL] [Abstract][Full Text] [Related]
16. UV dose determines key characteristics of nonmelanoma skin cancer.
Ramos J; Villa J; Ruiz A; Armstrong R; Matta J
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2006-11. PubMed ID: 15598755
[TBL] [Abstract][Full Text] [Related]
17. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
18. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
Nijsten TE; Stern RS
J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
Forman AB; Roenigk HH; Caro WA; Magid ML
Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
[TBL] [Abstract][Full Text] [Related]
20. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study.
Iannacone MR; Wang W; Stockwell HG; O'Rourke K; Giuliano AR; Sondak VK; Messina JL; Roetzheim RG; Cherpelis BS; Fenske NA; Rollison DE
BMC Cancer; 2012 Sep; 12():417. PubMed ID: 22994655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
